FDA Roundup: August 9, 2024
FDA Roundup: August 9, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-august-9-2024
FDA Roundup: August 9, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-august-9-2024
FDA Approves First Nasal Spray for Treatment of Anaphylaxis
http://www.fda.gov/news-events/press-announcements/fda-approves-first-nasal-spray-treatment-anaphylaxis
Cristina Mitchell
8 Aug 2024
FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose
http://www.fda.gov/news-events/press-announcements/fda-approves-first-nalmefene-hydrochloride-auto-injector-reverse-opioid-overdose
Cristina Mitchell
7 Aug 2024
Cristina Mitchell
6 Aug 2024
FDA Roundup: August 6, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-august-6-2024
FDA Roundup: August 2, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-august-2-2024
Cristina Mitchell
2 Aug 2024
FDA Approves First Gene Therapy to Treat Adults with Metastatic Synovial Sarcoma
http://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treat-adults-metastatic-synovial-sarcoma